Laurus Labs Ltd was trading at ₹1,389.5, up 1.14% on the day as of 12:49 IST on the NSE, marking its third consecutive session of gains. According to reports from Business Standard, the stock has demonstrated strong momentum with a 27.42% increase over the past month, significantly outperforming broader market indices.
The stock's performance contrasted with the broader market trends, as the benchmark NIFTY was up around 0.07% at 23,930.5, while the Sensex stood at 75,999.31, down 0.01%. As reported by Business Standard, the Nifty Pharma index, of which Laurus Labs is a constituent, was trading at 24,659.2, up 0.19% on the day and has gained 6.68% over the past month.
Trading volume for the stock stood at 9.51 lakh shares today, which was lower than the daily average of 25.19 lakh shares recorded over the past month. According to Business Standard, the benchmark June futures contract for Laurus Labs was quoting at ₹1,396.3, up 1.11% on the day, indicating positive sentiment in the derivatives market.
The stock has delivered exceptional returns over the longer term, gaining 127.6% in the last one year, significantly outperforming the 3.32% decline in the NIFTY and the 15.48% fall in the Nifty Pharma index. As reported by Business Standard, the stock's PE ratio stands at 100.13 based on trailing twelve months earnings ending March 2026.
